Lakefront Biotherapeutics American Depositary Shares (LKFT)
Stock · NASDAQ · Health Care
$28.88as of 8/28/2026
Price chart
Open in TradingViewActive signals
Support level
$28.59
Industry
Biotechnology: Pharmaceutical Preparations
About LKFT
Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 196
- Website
- www.glpg.com/
Fundamentals
- 1-day range
- $28.73$29.42
- Market cap
- $1.76B
- P/E (trailing)
- 3.29
- P/E (forward)
- -20.77
- EPS (trailing)
- $7.42
- Dividend yield
- —
- Beta
- 0.45
- Avg. volume
- 208.9K
52-week range
$22.32$27.12
Next earnings: November 12, 2026 · EPS estimate $-0.38confirmed
Forecasts
3 analyst ratings
Buy 17%
Hold 33%
Sell 50%
1-year price forecast
High
$26.08
-9.7%
Median
$26.08
-9.7%
Low
$18.95
-34.4%
Lakefront Biotherapeutics American Depositary Shares Competitors
Chosen by industry and closest market cap.
- LKFTLakefront Biotherapeutics American Depositary Shares$28.86▼ 1.97%Market cap $1.76BP/E 3.29$22.32$27.12
- ANIPANI Pharmaceuticals Inc.$72.83▼ 0.93%Market cap $1.80BP/E 18.72$70.15$99.5
- SNDXSyndax Pharmaceuticals Inc. Common Stock$19.55▼ 3.05%Market cap $1.70BP/E —$12.99$25.59
- BCAXBicara Therapeutics Inc. Common Stock$23.42▼ 5.70%Market cap $1.69BP/E —$10.3$30.99
- GENBGenerate Biomedicines Inc. Common Stock$15.33▼ 2.79%Market cap $1.84BP/E —$11$22.67
- OCULOcular Therapeutix Inc. Common Stock$10.36▼ 4.25%Market cap $1.84BP/E —$6.23$16.44
- STOKStoke Therapeutics Inc. Common Stock$31.61▼ 3.01%Market cap $1.84BP/E —$18.8$40.22
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| LKFT Lakefront Biotherapeutics American Depositary Shares | $1.76B | 3.29 | $28.86 | ▼ 1.97% | $22.32$27.12 |
| ANIP ANI Pharmaceuticals Inc. | $1.80B | 18.72 | $72.83 | ▼ 0.93% | $70.15$99.5 |
| SNDX Syndax Pharmaceuticals Inc. Common Stock | $1.70B | — | $19.55 | ▼ 3.05% | $12.99$25.59 |
| BCAX Bicara Therapeutics Inc. Common Stock | $1.69B | — | $23.42 | ▼ 5.70% | $10.3$30.99 |
| GENB Generate Biomedicines Inc. Common Stock | $1.84B | — | $15.33 | ▼ 2.79% | $11$22.67 |
| OCUL Ocular Therapeutix Inc. Common Stock | $1.84B | — | $10.36 | ▼ 4.25% | $6.23$16.44 |
| STOK Stoke Therapeutics Inc. Common Stock | $1.84B | — | $31.61 | ▼ 3.01% | $18.8$40.22 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Bank Of America Raises Lakefront Biotherapeutics Stake Above To 10.11%benzinga · 8/24/2026
- Morgan Stanley Maintains Equal-Weight on Lakefront Biotherapeutics, Lowers Price Target to $26Benzinga · 8/11/2026
- RBC Capital Maintains Sector Perform on Lakefront Biotherapeutics, Lowers Price Target to $26Benzinga · 8/11/2026
- Lakefront Biotherapeutics Q2 EPS $0.29 Beats $(13.52) Estimate, Sales $21.624M Beat $7.210M EstimateBenzinga · 8/10/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 31.73M
- Total value held
- $949.20M
- Institutional holders
- 88
Top holders this quarter
- Unknown16.71M
- Unknown3.79M
- Unknown2.47M
- Unknown1.67M
- Unknown1.55M
- Unknown1.42M
- Unknown482.7K
- Unknown462.7K
- Unknown426.4K
- Unknown332.1K
See the full, filterable feed with live charts on the MarketWall dashboard.